1. T cell pathways involving CTLA4 contribute to a model of acute lung injury.
- Author
-
Nakajima T, Suarez CJ, Lin KW, Jen KY, Schnitzer JE, Makani SS, Parker N, Perkins DL, and Finn PW
- Subjects
- Acute Lung Injury pathology, Animals, Antibodies, Monoclonal administration & dosage, Antigens, CD biosynthesis, Antigens, CD immunology, B-Lymphocyte Subsets immunology, B-Lymphocyte Subsets metabolism, B-Lymphocyte Subsets pathology, CTLA-4 Antigen, Female, Inflammation Mediators metabolism, Inflammation Mediators toxicity, Lipopolysaccharides physiology, Lipopolysaccharides toxicity, Lymphocyte Count, Lymphopenia immunology, Lymphopenia metabolism, Lymphopenia pathology, Mice, Mice, Inbred BALB C, Mice, Knockout, Severity of Illness Index, T-Lymphocyte Subsets pathology, Acute Lung Injury immunology, Acute Lung Injury metabolism, Antigens, CD physiology, Disease Models, Animal, Inflammation Mediators physiology, Signal Transduction immunology, T-Lymphocyte Subsets immunology, T-Lymphocyte Subsets metabolism
- Abstract
Acute lung injury (ALI) is a frequent pulmonary complication in critically ill patients. We characterized a murine model of LPS-induced ALI, focusing on Th cells. Following LPS administration, bronchoalveolar lavage lymphocytes, neutrophils, IL-6, TNF-alpha, and albumin were increased. Analysis of LPS-induced T cells revealed increased Th cell-associated cytokines (IL-17A, -17F, and -22), as well as increased expression of CD69 (a cell activation marker), Foxp3, and CTLA4 in CD4(+) T cells. Administration of anti-CTLA4 Ab decreased LPS-induced bronchoalveolar lavage albumin and IL-17A, while increasing CD4(+)Foxp3(+) cell number and Foxp3 expression in CD4(+)Foxp3(+) cells. These data suggest that pulmonary LPS administration promotes CD4(+) T cells and that T cell pathways involving CTLA4 contribute to ALI.
- Published
- 2010
- Full Text
- View/download PDF